After three days of networking, pitch refining and sharing sessions, one startup took home a big check, but all 10 startups won insights and exposure. The big winner, Organifarms, is creating automation technology for vertical farming systems.

Organifarms automates complex processes in indoor farming systems to make them profitable for the cultivation of fruit & vegetables.

To meet their customers needs, they adjust their technology to the crop types and functions they require and take care of the integration into the indoor farming environment.

By winning the Demo Day the team was given 5000€.

Event was co-organized and hosted at…


One platform, one solution, one world of corporate accommodation. Through a new strategic partnership with leading digital travel platform Booking.com, Acomodeo expands it’s “World of Serviced Apartments” to the “World of Corporate Accommodation”.

Acomodeo, the leading digital provider of serviced apartments, continues to expand its personal services and technology focusing on the evolving requirements of business travelers and their companies. The next leap is the option to combine Acomodeo’s existing professional long stay inventory with a variety of short-stay options provided by Booking.com to create an even wider choice of corporate accommodation within the Acomodeo platform.

This partnership enables Acomodeo…


Today, we’re proud to announce that GraphCMS has closed a $10M Series A round led by OpenOcean to help realize the vision of building unified Content APIs and Federating the Content Layer. We’re excited to share that this is OpenOcean’s largest single investment to date, and Ekaterina Almasque, General Partner at OpenOcean, will be joining the board.

Previous investors Peak and Paua Ventures also participated in this round. Mango Capital’s Robin Vasan (investor in HashiCorp, Netlify, and others), Fauna founder and CTO, Evan Weaver, and Instana (acquired by IBM) founder and CEO Mirko Novakovic also joined as strategic investors, bringing…


MainFirst Asset Management has surpassed the 5 billion euro mark in terms of assets under management. With a clear and stringent focus on its core competence, active stock selection, the multi-investment boutique is continuing its growth course: In addition to the continuous expansion of its sustainability approach, MainFirst intends to opportunistically exploit growth opportunities by expanding its product range and investment teams.

It is the start of a new growth offensive: For the first time, MainFirst has surpassed the €5 billion mark in assets under management. Moreover, MainFirst has entered the top ten of its peer group for the first…


BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Kite, a Gilead Company (Nasdaq: GILD, “Kite”) today announced the two companies have entered into a purchase agreement for BioNTech to acquire Kite’s solid tumor neoantigen T cell receptor (TCR) R&D platform and clinical manufacturing facility in Gaithersburg, MD. The acquired Gaithersburg facility will provide production capacity to support clinical trials in the United States and will complement BioNTech’s existing cell therapy manufacturing facility in Idar-Oberstein, Germany. …


Frankfurter Fintech iVE.ONE, a global platform fordigital assets, closed a successful pre-series A+ funding round with CV VC AG,a Swiss-based investment company that’s focusing on blockchain technology andcrypto assets.‍

· iVE.ONE receives investment from Swiss-based CV VC AG

· Confidence in digital assets and cryptocurrenciescontinues to grow

· Stronger focus on the iVE.ONE Investment Hub

Frankfurt-based Fintech Agora Innovation secures another investment forthe development of their platform iVE.ONE. The financing round was closed withan investment from Swiss-based venture capitalist CV VC AG with a broad networkin crypto valley.

iVE.ONE is unique in its technology enabled platform and infrastructure,which grant corporates…


MAGNOTHERM recently announced the closing of a 600,000 EUR (~700,000 USD) financing round. The funding comes from the German federal government’s 2 billion EUR package of measures for startups, which is being handled through various VCs. In the case of MAGNOTHERM, the fund is handled by High-Tech Gründerfonds, to whom a close collaboration and partnership already exists.

Timur Sirman, Co-Founder and Co-CEO of MAGNOTHERM, states: “We are happy that after the 1.4 million EUR (~1.6 million USD) pre-seed fundings from the Germany Federal Ministry of Economic Affairs and Energy with EXIST Forschungstransfer as well as the other programs from ESA


It’s almost time! EMERGE 2021 an initiative by AHK Argentina — Cámara de Industria y Comercio Argentino-Alemana together with Mainstage Incubator & Hessen Trade & Invest GmbH is right around the corner. We now have the 9 finalists who will be competing against each other for a chance to anchor themselves in Frankfurt and then scale globally through the renowned incubation program by Mainstage Incubator.

The event is scheduled to be held on Tuesday the 20th of July, 17:00 CET onwards.

Join us: https://www.airmeet.com/e/c8c7d3c0-dbfd-11eb-9a99-ab8bbdcc284b

Meet the decorated panel of judges who will be reviewing the startups:-

  • Debasis Chakraborty (COO &…

Frankfurt-based legal tech start-up Lintum disclosed this week the achivement of a miletsone: the team successfully closed its second financing round with BMH Beteiligungs-Managementgesellschaft Hessen mbH and leading figures from the German legal market in May 2021.

Frankfurt-based legal tech start-up Lintum successfully closed its second financing round with BMH Beteiligungs-Managementgesellschaft Hessen mbH and leading figures from the German legal market in May 2021. The total volume of the financing round was €800,000, of which €400,000 came from BMH via the Participation Fund Hessen Kapital III (EFRE) GmbH, which it manages. …


Merck, a leading science and technology company, today announced a second collaboration agreement in its Bioelectronics innovation field with Innervia Bioelectronics, a start-up and subsidiary of Inbrain Neuroelectronics S.L., Barcelona, Spain. The aim of the collaboration is to co-develop the next generation of graphene-based bioelectronic vagus nerve therapies targeting severe chronic diseases within the therapeutic areas addressed by Merck.

“We aim to accelerate developments in the emerging field of bioelectronics by boosting the novel modality of selective neurostimulation,” said Laura Matz, Chief Science and Technology Officer of Merck. “Today’s agreement with Innervia Bioelectronics gives Merck access to a unique technology…

Pedro Gonçalo Ferreira

Editor in chief of FRANKFURT VALLEY

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store